MedTrace Logo

A Pragmatic Clinical Trial of MyPEEPS Mobile to Improve HIV Prevention Behaviors in Diverse Adolescent MSM

NCT03167606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 764

Last updated 2023-02-23

Study results available
· View outcomes & findings →

Summary

The proposed MyPEEPS Mobile intervention is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information specifically developed for at-risk young men who have sex with men (YMSM). This will be the one of the first studies to test the efficacy of a scaled-up, mobile version of an existing human immunodeficiency virus (HIV) prevention intervention originally developed for, designed by, and piloted for, a diverse group of YMSM.

MyPEEPS Mobile will be tested in an randomized controlled trial with racially and ethnically diverse HIV-negative or unknown status YMSM aged 13-18 at four geographically diverse sites: Birmingham, Chicago, New York City, and Seattle, allowing for increased generalizability of findings.

Conditions

  • HIV Infections

Interventions

BEHAVIORAL

MyPEEPS Mobile

Mobile technology to deliver HIV prevention information specifically developed for at-risk YMSM.

Sponsors & Collaborators

  • University of Washington

    collaborator OTHER

  • New York Blood Center

    collaborator OTHER

  • University of Alabama at Birmingham

    collaborator OTHER

  • Ann & Robert H Lurie Children's Hospital of Chicago

    collaborator OTHER

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Columbia University

    lead OTHER

Principal Investigators

  • Rebecca Schnall, PhD · Columbia University School of Nursing

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
13 Years
Max Age
18 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2021-05-13
Completion
2021-05-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03167606 on ClinicalTrials.gov